title: Absorption and tolerability of aqueous chlorhexidine gluconate used for skin antisepsis prior to catheter insertion in preterm neonates.
abstract: OBJECTIVE
  To assess chlorhexidine absorption and skin tolerability in premature infants, following skin antisepsis with 2% aqueous chlorhexidine gluconate (CHG) prior to peripherally inserted central catheter (PICC) placement.
  
  
  METHODS
  Neonates less than 32 weeks gestation had skin cleansed with CHG prior to PICC placement. CHG concentrations were measured on serial blood samples. Skin integrity was evaluated for 2 weeks after CHG exposure.
  
  
  RESULTS
  Twenty infants were enrolled; median gestational age was 28 2/7 weeks (range 24 3/7 to 31 4/7). Ten infants had detectable serum chlorhexidine concentrations (range 1.6 to 206 ng ml(-1)). Seven of these infants had their highest serum concentration 2 to 3 days following exposure. No CHG-related skin irritation occurred in any infant.
  
  
  CONCLUSIONS
  CHG was detected in the blood of preterm infants receiving CHG skin antisepsis for PICC insertion. Highest serum concentrations occurred 2 to 3 days after exposure. Further investigation is needed to determine the clinical relevance of CHG absorption in preterm infants.
authors.affiliation: Division of Neonatology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: A K
authors.initials: AK
authors.lastname: Chapman
authors.forename: S W
authors.initials: SW
authors.lastname: Aucott
authors.forename: M M
authors.initials: MM
authors.lastname: Gilmore
authors.forename: S
authors.initials: S
authors.lastname: Advani
authors.forename: W
authors.initials: W
authors.lastname: Clarke
authors.forename: A M
authors.initials: AM
authors.lastname: Milstone
mesh_terms: D000042:Absorption; D000891:Anti-Infective Agents, Local / Q000097:blood / Q000493:pharmacokinetics*; D000985:Antisepsis / Q000379:methods; D002406:Catheterization, Peripheral; D002710:Chlorhexidine / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D002853:Chromatography, Liquid; D005260:Female; D006801:Humans; D007224:Infant Care; D007231:Infant, Newborn; D007234:Infant, Premature; D008297:Male; D010865:Pilot Projects; D012869:Skin Absorption / Q000187:drug effects*; D053719:Tandem Mass Spectrometry
chemical_list: D000891:Anti-Infective Agents, Local; C010882:chlorhexidine gluconate; D002710:Chlorhexidine